» Articles » PMID: 17314515

HIV1 Vpr Arrests the Cell Cycle by Recruiting DCAF1/VprBP, a Receptor of the Cul4-DDB1 Ubiquitin Ligase

Overview
Journal Cell Cycle
Specialty Cell Biology
Date 2007 Feb 23
PMID 17314515
Citations 177
Authors
Affiliations
Soon will be listed here.
Abstract

How the HIV1 Vpr protein initiates the host cell response leading to cell cycle arrest in G(2) has remained unknown. Here, we show that recruitment of DCAF1/VprBP by Vpr is essential for its cytostatic activity, which can be abolished either by single mutations of Vpr that impair DCAF1 binding, or by siRNA-mediated silencing of DCAF1. Furthermore, DCAF1 bridges Vpr to DDB1, a core subunit of Cul4 ubiquitin ligases. Altogether these results point to a mechanism where Vpr triggers G(2) arrest by hijacking the Cul4/DDB1(DCAF1) ubiquitin ligase. We further show that, Vpx, a non-cytostatic Vpr-related protein acquired by HIV2 and SIV, also binds DCAF1 through a conserved motif. Thus, Vpr from HIV1 and Vpx from SIV recruit DCAF1 with different physiological outcomes for the host cell. This in turn suggests that both proteins have evolved to preserve interaction with the same Cul4 ubiquitin ligase while diverging in the recognition of host substrates targeted for proteasomal degradation.

Citing Articles

VprBP regulates osteoclast differentiation via an epigenetic mechanism involving histone H2A phosphorylation.

Shin Y, Kim S, Choi T, Kim C, An W Epigenetics Chromatin. 2024; 17(1):35.

PMID: 39587626 PMC: 11590243. DOI: 10.1186/s13072-024-00561-7.


CRL4-DCAF1 Ubiquitin Ligase Dependent Functions of HIV Viral Protein R and Viral Protein X.

Dobransky A, Root M, Hafner N, Marcum M, Sharifi H Viruses. 2024; 16(8).

PMID: 39205287 PMC: 11360348. DOI: 10.3390/v16081313.


SLC12A8 upregulation promotes colorectal cancer progression and chemoresistance.

Sun Z, Nie Z, Xu Y, Cui Y, Ma W, Zhang T Transl Cancer Res. 2024; 13(7):3446-3464.

PMID: 39145047 PMC: 11319960. DOI: 10.21037/tcr-24-87.


Glucose deprivation triggers DCAF1-mediated inactivation of Rheb-mTORC1 and promotes cancer cell survival.

Li M, Huang W, Zhang Y, Du Y, Zhao S, Wang L Cell Death Dis. 2024; 15(6):409.

PMID: 38862475 PMC: 11166663. DOI: 10.1038/s41419-024-06808-1.


DCAF1 interacts with PARD3 to promote hepatocellular carcinoma progression and metastasis by activating the Akt signaling pathway.

Zhang J, Shi Y, Ding K, Yu W, He J, Sun B J Exp Clin Cancer Res. 2024; 43(1):136.

PMID: 38711082 PMC: 11071249. DOI: 10.1186/s13046-024-03055-2.